Caricamento...

Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDA) is a lethal malignancy with an overall 5-year survival rate of 10%. Disease lethality is due to late diagnosis, early metastasis and resistance to therapy, including immunotherapy. PDA creates a robust fibroinflammatory tumor microenvironment that contributes t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Schmiechen, Zoe C., Stromnes, Ingunn M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7876239/
https://ncbi.nlm.nih.gov/pubmed/33584701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.613815
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !